Innovative Research Combines Ayurvedic Medicine and Chemically Designed Peptides to Combat Amyloid Aggregation in ...

Lab-grown mini-brains help scientists explore how concussions reactivate latent viral infections, triggering molecular ...

This phenotype adds to cognitive decline and neurodegeneration alongside AD pathology, redefining how CeVD’s role in dementia ...

The current human tissue-based study provides convincing evidence correlating hippocampal expressions of RNA guanine-rich G-quadruplexes with aging and with Alzheimer's Disease presence and severity.

Researchers have identified how cerebrovascular disease (CeVD) disrupts brain connectivity, contributing to cognitive decline and neurodegeneration alongside Alzheimer’s disease (AD).

Sleep disturbances encompass a broad range of disorders, such as insomnia, restless legs syndrome, parasomnias, sleep-disordered breathing, daytime ...

Our findings highlight the potential of brain connectome-based markers to track cognitive decline, particularly for ...

There are two kinds of risk factors for dementia: non-modifiable and modifiable. Non-modifiable risk factors are ones that cannot be changed or eliminated, like aging, family history and genetics.

People with Alzheimer’s and other types of dementia tend to be at a high risk of falling. They are more than three times more likely to fracture their hip when they fall, which leads to surgery and ...

Cognitive decline/dementia is of subcortical vascular type ... mainly located in cerebral WM and deep GM. The exact pathogenesis is still open. Despite the mutations, the canonical Notch3 ...

ApoE is a key genetic risk factor for certain forms of Alzheimer's disease, whose 3 variants (E2, E3, E4) influence the progression of the disease in different ways. People carrying the E4 allele have ...